Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes

ClinicalTrials.gov ID: NCT01994642

Public ClinicalTrials.gov record NCT01994642. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 6:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel Design, Multiple-Site Study to Evaluate the Clinical Equivalence of Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspension (Par) Compared to CIPRODEX® (Ciprofloxacin 0.3%/Dexamethasone 0.1%) Sterile Otic Suspension (Alcon) in the Treatment of Acute Bacterial Otitis Media in Children With Patent Tympanostomy Tubes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to compare the relative efficacy and safety of the test formulation of ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension (Par) to the already-marketed formulation CIPRODEX® (ciprofloxacin 0.3%/dexamethasone 0.1%) sterile otic suspension (Alcon) in the treatment of acute bacterial otitis media in children with patent tympanostomy tubes.

Study identification

NCT ID
NCT01994642
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Par Pharmaceutical, Inc.
Industry
Enrollment
203 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Months to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2013 (Type not available)
Primary completion
Mar 2015 (Actual)
Completion
Mar 2015 (Actual)
Last update posted
Sep 26, 2017

2013 – 2015

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Birmingham Pediatrics Birmingham Alabama 32505 —
Agave Clinical Ressearch Mesa Arizona 85202 —
Arizona Center for Clinical Trials Phoenix Arizona 85003 —
Visions Clinical Research, Tuscon Tucson Arizona 85712 —
Alliance Research Long Beach California 90813 —
San Marcus Research Clinic Miami Florida 33015 —
Florida Medical Center and Research Inc. Miami Florida 33142 —
South Miami Clinical Research Group Miami Florida 33142 —
Miami Dade Medical Resarch Institute Miami Florida 33176 —
Global Health Research Center Miami Lakes Florida 33016 —
Winter Park Clinical Research Winter Park Florida 32792 —
Research Integrity Owensboro Kentucky 42303 —
Dr. Craig Spiegel Bridgeton Missouri 63044 —
Dr. Scott Mathei Henderson Nevada 89704 —
Piedmont Ear Nose and Throat Associates, PA Winston-Salem North Carolina 27103 —
Accecss MD, Clinical Resarch Huber Heights Ohio 45424 —
Cyn3gry Gresham Oregon 97030 —
Rainbow Research, Inc Barnwell South Carolina 29812 —
Dr. John Ansley Orangeburg South Carolina 29118 —
Spartanburg and Greer ENT Spartanburg South Carolina 29303 —
PMG Research of Bristol Bristol Tennessee 37620 —
Eagle Family Medical Associates Crossville Tennessee 38555 —
The Education and Research Foundation, Inc Lynchburg Virginia 24501 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01994642, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 26, 2017 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01994642 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →